Health Sciences and Biotechnology

Leveraging decades of experience building and operating early-stage resource and technology companies around the globe, Forbes & Manhattan is uniquely positioned with the resources and network to tackle emerging global health challenges.

With a proven track-record of financing companies, cumulatively raising billions of dollars, seemingly insurmountable problems become manageable with the right combination of resources. Forbes’s team of advisors has included renowned figures such as General Lewis Mackenzie, Larry King, and Bernard Wilson.

In the Health Sciences and Biotecnology sector, Forbes’ strategy is no different, secure the capital and assemble a team of world-renowned experts.

ENTER QUESTCAP

Forbes & Manhattan’s marque company in the Health Sciences and Biotechnology sector is QuestCap Inc. (CSE:QSC; FRA:34C1). The company is a growth focused investment-issuer that is bringing to market innovative technologies and therapies to help turn the tide against COVID-19. It has invested in the three key areas to help society return to normal - prevention, detection, and treatment - however, its complete testing solution remains its primary focus.

QuestCap is combining advanced COVID-19 testing technology with proprietary operating protocols to create a differentiated testing solution with protected margins.

COVID-19 & QUESTCAP

The COVID-19 pandemic has grown at an unprecedented rate, surprising even the most advanced medical experts. Globally, it has ground economies to a halt and leaving society in crisis. This has created an opportunity for companies with the financial resources and expertise to come to the aid of society.

COVID-19 SOLUTION: TESTING

The COVID-19 pandemic has created demand for technologies across three categories; prevention, detection, and treatment. While all crucial in helping society minimize impact, the effectiveness of COVID-19 management is proportional to the quality and speed of testing.

According the Harvard researchers, the United States alone requires 500,000 tests per day to safely reopen in May(2).

Testing (MTJR) <

QuestCap has partnered with U.S. based MTJR to distribute COVID-19 Rapid IgG/IgM Antibody Test Kits (https://serocovid.com/). MTJR Partnership details include a 40% profit sharing agreement for tests sold in North and South America.

Protocols <

QuestCap is helping develop and implement a series of protocols for businesses and people to return to normal operation in a COVID-19 environment. These standards can provide users a sense of security that differentiates its COVID-19 testing solutions.

First among many proprietary protocols is the Standard for Safe Sport™, a trademark of Glenco Medical. Created from decades of experience by Dr. Glenn Copeland and his company Glenco Medical Corp. with assistance from Dr Steinman (immunology expert), the Standard for Safe Sport™ is the guideline for professional sports leagues to demonstrate their commitment to a safe environment.

Prevention & Treatment Partnerships <

QuestCap has partnered with renowned public research institutions and innovative private enterprises to provide investment capital to develop game-changing technologies. Below is an overview of the key partnerships to date.

COVID-19 Vaccine Disclaimer:

QuestCap cautions that this is still early stage research and development and is not making any express or implied claims that it has the ability to treat the SARS-CoV-2 virus at this time.

Meet the Team <

DOUGLAS SOMMERVILLE

Doug has held prominent roles at pharmaceutical giants such as Teva Pharmaceuticals and Baxter Healthcare International. In this role as Head of Teva Canada, Mr. Sommerville was responsible for Teva’s third largest global subsidiary, with sales in excess of $1.3 billion. Doug was also the Chairman of the Canadian Generic Pharmaceutical Association up until his retirement from Teva Canada in 2018. He holds an MBA from the Schulich School of Business.

Dr. GLENN COPELAND

Possessing over 45 years of experience in both orthopaedic treatment and sports medicine, Dr. Glenn Copeland is one of North America’s most prominent foot and ankle specialists. Between 2002 and 2008, Dr. Copeland was selected to be the founder, chairman, and CEO of Cleveland Clinic Canada. Cleveland Clinic is universally regarded as one of the top three medical institutions in the world.

Dr. JOSEPH SUGERMAN

Dr. Sugerman is a board-certified otolaryngologist who manages a private practice in Los Angeles focused on the management of voice disorders. He is a past Clinical Chief at Cedars-Sinai Medical Centre. He is also a former board member of MGM Mirage. Dr. Sugerman was a Clinical Instructor at the University of Southern California (USC) Keck School of Medicine and the University of California at Los Angeles (UCLA) Department of Otolaryngology: Head and Neck Surgery Division.

Dr. LAWRENCE STEINMAN

Dr. Steinman is Professor of Neurology, Neurological Sciences and Paediatrics at Stanford University and was Chair of the Stanford Program in Immunology from 2001 to 2011. His research focuses on antigen specific tolerance in autoimmune disease and in gene therapy for degenerative neurologic diseases. Dr. Steinman has elucidated what provokes relapses and remissions in multiple sclerosis (MS). He serves as attending neurologist at Stanford’s Lucille Packard Children’s Hospital.

THE STANDARD FOR SAFE SPORT

MedQuest is helping develop and implement a series of protocols for businesses and people to return to normal operation in a COVID-19 environment.

These standards can provide users a sense of security that differentiates MedQuest’s COVID-19 testing solutions.

First among many proprietary protocols is the
Standard for Safe Sport™, a trademark of Glenco Medical.

Created from decades of experience by Dr. Glenn Copeland and his company Glenco Medical Corp. with assistance from Dr Steinman (immunology expert), the Standard for Safe Sport™ is the guideline for professional sports leagues to demonstrate their commitment to a safe environment.

STANDARD FOR SAFE SPORT INVESTMENT:
GLENCO MEDICAL CORP.

PARTNERSHIP: GLENCO MEDICAL

Glenco Medical recently established the COVID-19 Standard for Safe Sport, Industry, School, Set, and Retail, through which it is developing and implementing protocols to safely return sports players, businesspeople, students, performers and shoppers to their respective professions and passions.

Under the arrangement

QuestCap has acquired a 30% in Glenco Medical Corp.
The Standards are designed by Dr. Glenn Copeland with input from other medical professionals. This partnership and the associated protocols compliment other QuestCap partnerships and augments our COVID-19 testing solution.

The Standards help ensure participant safety and mitigate the potential spread of coronavirus. It is overseen by independent medical administrators, who enforce medical recommendations and public health safety measures.

The Standards include:
- COVID-19 testing and COVID-19 antibody testing for individuals and staff by trained and certified clinicians.
- Self-reporting, identification of tested, aggregation of test results and collaboration with governing bodies.
- Self-regulation, by enforcing medical recommendations and measures for recovery.
- Digital ID verification, authentication and credential management through a digital app.
- Contact tracing in order to help identify, educate, and monitor the spread and impact of the virus.